Frequency of attainment of low-density lipoprotein cholesterol and non-high-density lipoprotein cholesterol goals in cardiovascular clinical practice (from the National Cardiovascular Data Registry PINNACLE Registry)

American Journal of Cardiology

Volumn 116, Issue 4, 2015, Pages 547-553

  Spinler, Sarah A ^a   Cziraky, Mark J ^a,b   Willey, Vincent J ^a,b   Tang, Fengming ^c   Maddox, Thomas M ^d   Thomas, Tyan ^a   Dueñas, Gladys G ^a   Virani, Salim S ^e  

^a UNIVERSITY OF THE SCIENCES   (United States)

^b HEALTHCORE INC   (United States)

^c SAINT LUKE S MID AMERICA HEART INSTITUTE   (United States)

^d UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

^e BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANGIOTENSIN RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; CLOPIDOGREL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ADULT; ARTICLE; CEREBROVASCULAR ACCIDENT; CLINICAL PRACTICE; COHORT ANALYSIS; COMORBIDITY; COMPARATIVE STUDY; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DIABETES MELLITUS; DISEASE ASSOCIATION; DYSLIPIDEMIA; EDUCATION PROGRAM; FEMALE; GOAL ATTAINMENT; HEALTH EDUCATION; HEART INFARCTION; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; MEDICAL HISTORY; MIDDLE AGED; PERIPHERAL OCCLUSIVE ARTERY DISEASE; PREVALENCE; PRIORITY JOURNAL; SMOKING; TRANSIENT ISCHEMIC ATTACK; AGE; AGED; BLOOD; CARDIOVASCULAR DISEASES; COMPLICATION; DYSLIPIDEMIAS; OUTCOME ASSESSMENT; PRACTICE GUIDELINE; REGISTER; SEX DIFFERENCE; UNITED STATES;

AGE FACTORS; AGED; CARDIOVASCULAR DISEASES; CHOLESTEROL, HDL; CHOLESTEROL, LDL; COHORT STUDIES; DIABETES COMPLICATIONS; DYSLIPIDEMIAS; FEMALE; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; MALE; MIDDLE AGED; OUTCOME ASSESSMENT (HEALTH CARE); PRACTICE GUIDELINES AS TOPIC; REGISTRIES; SEX FACTORS; UNITED STATES;

EID: 84938213583     PISSN: 00029149     EISSN: 18791913     Source Type: Journal    
DOI: 10.1016/j.amjcard.2015.05.011     Document Type: Article

References (17)

1. N.J. Stone, J. Robinson, A.H. Lichtenstein, C.N. Merz, C.B. Blum, R.H. Eckel, A.C. Goldberg, D. Levy, D.M. Lloyd-Jones, P. McBride, J.S. Schwartz, S.T. Shero, S.C. Smith Jr., K. Watson, P.W. Wilson, K.M. Eddleman, N.M. Jarrett, K. LaBresh, L. Nevo, J. Wnek, J.L. Anderson, J.L. Halperin, N.M. Albert, B. Bozkurt, R.G. Brindis, L.K. Curtis, D. DeMets, J.S. Hochman, R.K. Kovacs, E.M. Ohman, S.J. Pressler, F.W. Sellke, W.K. Shen, S.C. Smith, and G.F. Tomaselli 2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines Circulation 129 25 Suppl 2 2014 S1 S45
2. T.J. Jacobsen, M.K. Ito, K.C. Maki, C.E. Orringer, H.E. Bays, P.H. Jones, J.M. McKenney, S.M. Grundy, E.A. Gill, R.A. Wild, D.P. Wilson, and W.V. Brown National Lipid Association recommendations for patient-centered management of dyslipidemia (Part 1) J Clin Lipidol 8 2014 473 488
3. Cardiovascular disease and risk management Diabetes Care 38 Suppl 1 2015 S49 S57
4. Expert Panel on Dyslipidemia An International Atherosclerosis Society position paper: global recommendations for the management of dyslipidemia: executive summary Atherosclerosis 232 2014 410 413
5. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive summary on the third report of the national cholesterol education program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III) Final report Circulation 106 2002 3143 3421
6. S.M. Grundy, C. Cleeman, C.N. Bairey, H.B. Brewer, L.T. Clark, D.B. Hunninghake, R.C. Pasternak, S.C. Smith Jr., N.J. Stone National Heart Lung and Blood Institute American College of Cardiology Foundation American Heart Association Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines Circulation 110 2004 227 239
7. R.B. D'Agostino Sr., R.S. Vasan, M.J. Pencina, P.A. Wolf, M. Cobain, J.M. Massaro, and W.B. Kannel General cardiovascular risk profile for use in primary care: the Framingham Heart Study Circulation 117 2008 743 753
8. S.M. Boekholdt, B.J. Arsenault, G.K. Hovingh, S. Mora, T.R. Pedersen, J.C. Larosa, K.M. Welch, P. Amarenco, D.A. Demicco, A.M. Tonkin, D.R. Sullivan, A. Kirby, H.M. Colhoun, G.A. Hitman, D.J. Betteridge, P.N. Durrington, M.B. Clearfield, J.R. Downs, A.M. Gotto Jr., P.M. Ridker, and J.J. Kastelein Levels and changes of HDL cholesterol and apolipoprotein A-I in relation to risk of cardiovascular events among statin-treated patients: a meta-analysis Circulation 128 2013 1504 1512
9. D.D. Waters, C. Brotons, C.W. Chiang, J. Ferrieres, J. Foody, J.W. Jukema, R.D. Santos, J. Verdejo, M. Messig, R. McPherson, K.B. Seung, and L. Tarasenko Lipid treatment assessment project 2: a multinational survey to evaluate the proportion of patients achieving low-density lipoprotein cholesterol goals Circulation 120 2009 28 34
10. S.S. Virani, L.D. Woodard, C.R. Landrum, K. Pietz, D. Wang, C.M. Ballantyne, and L.A. Petersen Institutional, provider, and patient correlates of low-density lipoprotein and non-high-density lipoprotein cholesterol goal attainment according to the Adult Treatment Panel III guidelines Am Heart J 161 2011 1140 1146
11. G. Hess, C.L. Chang, and K. Chung Lipid attainment among patients newly treated with lipid-altering drugs Curr Med Res Opin 30 2014 1743 1756
12. M.C. Tattersall, R.E. Gangnon, K.N. Karmali, M.W. Cullen, J.H. Stein, and J.G. Keevil Trends in low-density lipoprotein cholesterol goal achievement in high risk United States adults: longitudinal findings from the 1999-2008 National Health and Nutrition Examination Surveys PLoS One 8 2013 e59309
13. M.J. Cziraky, M.F. Bullano, J. Yu, R. Schiebinger, and V.J. Willey Impact of optimal lipid value achievement between 2005 and 2009 in patients with mixed dyslipidaemia on cardiovascular event rates Int J Clin Pract 65 2011 425 435
14. S.V. Arnold, J.A. Spertus, F. Tang, H.M. Krumholz, W.B. Borden, S.A. Farmer, H.H. Ting, and P.S. Chan Statin use in outpatients with obstructive coronary artery disease Circulation 124 2011 2405 2410
15. T.M. Maddox, W.B. Borden, F.M. Tang, S.S. Virani, W.J. Oetgen, J.B. Mullen, P.S. Chan, P.N. Casale, P.S. Douglas, F.A. Masoudi, S.A. Farmer, and J.S. Rumsfeld Implications of the 2013 ACC/AHA cholesterol guidelines for adults in contemporary cardiovascular practice: insights from the NCDR PINNACLE Registry J Am Coll Cardiol 64 2014 2183 2192
16. C. Li, E.S. Ford, J. Tsai, G. Zhao, L.S. Balluz, and S.S. Gidding Serum non-high-density lipoprotein cholesterol concentration and risk of death from cardiovascular diseases among U.S. adults with diagnosed diabetes: the Third National Health and Nutrition Examination Survey linked mortality study Cardiovasc Diabetol 10 2011 46
17. J.R. Guyton, D.J. Betteridge, M. Farnier, L.A. Leiter, J. Lin, A. Shah, A.O. Johnson-Levonas, and P. Brudi Achievement of recommended lipid and lipoprotein levels with combined ezetimibe/statin therapy versus statin alone in patients with and without diabetes Diab Vasc Dis Res 8 2011 160 172